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The Burkholderia cepacia complex (Bcc) is a group of opportunistic pathogenic bacteria
with a remarkable metabolic capacity and broad genotypic/phenotypic plasticity, allowing
their adaptation to hostile conditions, including nutrient depleted solutions containing
antimicrobial agents. Bcc bacteria are feared contaminants in pharmaceutical industries
and cause nosocomial outbreaks, posing health threats to immunocompromised
individuals and cystic fibrosis (CF) patients. In this study, the adaptation and survival of
B. cepacia and B. contaminans isolates was investigated after long-term incubation in
nutrient depleted saline solutions supplemented with increasing concentrations of the
biocidal preservative benzalkonium chloride (BZK), recreating the storage conditions
of pharmaceutical products. These epidemiologically related isolates were recovered
from intrinsically contaminated saline solutions for nasal application and from two CF
patients. Long-term incubation in saline solutions containing BZK led to the development
of bacterial sub-populations that survived for at least 16 months, despite an initial
2–3 log decrease in viability, displaying a progressive dose-dependent decrease of
colony and cell size, including the appearance of small colony variants (SCVs). Bacterial
colonies lost pigmentation, changed the morphotype from rough to smooth and
produced more spherical cells during extended incubation with BZK. The development
of macroscopically visible cellular aggregates, rich in polysaccharide and harboring viable
cells in their interior was triggered by BZK. The existence of a metabolic pathway for BZK
degradation was confirmed through genome analysis. This study reveals mechanisms
underlying the prevalence of Bcc bacteria as contaminants of pharmaceutical products
containing BZK, which often lead to false-negative results during quality control and
routine testing.
Keywords: Burkholderia cepacia complex, Burkholderia cepacia, Burkholderia contaminans, pharmaceutical
products’ contamination, nutrient starvation adaptation, benzalkonium chloride adaptation, small colony variants
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INTRODUCTION
The Burkholderia cepacia complex (Bcc) is a group of Gram-
negative β-proteobacteria with an ubiquitous environmental
distribution (Compant et al., 2008), that have emerged as
human opportunistic pathogens able to cause severe infections
in patients with underlying disease, namely cystic fibrosis (CF)
and chronic granulomatous (Mahenthiralingam et al., 2005;
Eberl and Vandamme, 2016), and in immunocompromised
individuals. Chronic Bcc infections are very difficult to
eradicate, mainly due to their intrinsic resistance to a
large number of antimicrobials and their ability to adapt
to the adverse conditions that characterize the human host
(Coutinho et al., 2011b). Bcc bacteria are well-known for
their ability to remain viable for prolonged periods of time
in hostile conditions (Torbeck et al., 2011), being commonly
associated with contamination of water-based environments,
solutions with low nutrient concentrations and pharmaceutical
products containing antimicrobial agents (disinfectant solutions,
hospital soaps, nasal sprays, mouth wash, and anesthetics)
(Sutton and Jimenez, 2012; Jimenez et al., 2015; Ali, 2016).
Numerous reports of Bcc-related nosocomial outbreaks have
been published in the last decades (Tavares et al., 2020),
and multiple products have been recalled from the market
(United States Food Drug Administration, 2019), due to
contamination with this group of bacteria, highlighting the
potential public health threat imposed by these objectionable
microorganisms (Mahenthiralingam et al., 2005; Sutton and
Jimenez, 2012).
Multiple contamination outbreaks have been linked, in
particular, to the biocide benzalkonium chloride (BZK), a
cationic quaternary ammonium compound that exerts its effects
by compromising the structure and stability of the cytoplasmic
membrane (McDonnell and Russell, 1999; Weber et al., 2007;
Fazlara and Ekhtelat, 2012). This biocide is included in a
variety of commercially available products’ formulation, at
concentrations ranging from 200 to 50,000µg/mL (Kim et al.,
2015). Several reports and studies have demonstrated that
biocides, when present in low concentrations (referred to as
preservatives), do not prevent contamination, since some Bcc
strains are able to persist in preserved solutions (Avgeri et al.,
2009; Rose et al., 2009; Torbeck et al., 2011; Buffet-Bataillon
et al., 2012; Ahn et al., 2016, 2017). The best described Bcc
species in terms of BZK resistance is B. cenocepacia AU1054,
the strain used by Ahn et al. (2016) to perform transcriptomic
studies that allowed the identification of two main mechanisms
responsible for BZK resistance (efflux activity and metabolic
inactivation through biodegradation), as well as a putative
metabolic pathway responsible for its degradation (Ahn et al.,
2016).
When exposed to stressful conditions, Bcc populations can
undergo phenotypical and genetic adaptations that confer
selective advantage. One example of such versatility is the
formation of small colony variants (SCVs), which typically
exhibit one-tenth the size of the colonies associated with
the parent strain, and are characterized by a slow specific
growth rate (Häussler et al., 1999; Proctor et al., 2006;
Kahl, 2014; Bui and Kidd, 2015). Besides being considered
a pathogenesis factor, formation of SCVs is also thought
to contribute for the establishment of recurrent infections,
leading to lung function deterioration and development of
fatal systemic infections (Häussler et al., 2003; Proctor et al.,
2006). As SCVs require prolonged incubation periods for
their manifestation, they are mostly overgrown by normal-
sized colonies, making their isolation and identification a
difficult task (Torbeck et al., 2011; Jimenez et al., 2015),
which can lead to false-negative results during quality control
and routine testing during pharmaceutical manufacturing
(Jimenez et al., 2015). The undetected presence of Bcc
bacteria constitutes a serious healthcare problem, especially
if these contaminated products are used by susceptible
patients, negatively affecting their treatment options and
general prognosis.
An unusually high frequency of B. cepacia infections was
detected among the Portuguese CF community, in the period
between 1995 and 2005, affecting as much as 85% of the CF
patients under surveillance at the major Portuguese CF center
at Hospital de Santa Maria (HSM) in Lisbon (Cunha et al.,
2003, 2007). A routine market surveillance analysis performed
by INFARMED, the Portuguese Medicines and Health Products
Authority, in 2003 and 2006, revealed that several batches of non-
sterile saline solutions used for nasal application, produced by
two local manufacturers, greatly exceeded the microbiological
quality limits established by European Pharmacopoeia VII,
and B. cepacia bacteria were subsequently isolated from those
products (Cunha et al., 2007). Further analysis confirmed that
the clinical clones obtained from CF patients and the strains
detected in saline solutions were indistinguishable (Cunha et al.,
2007). When this outbreak occurred, all of the clones identified
by our laboratory were classified as B. cepacia. In 2015, a re-
examination of the isolates was conducted and 20 out of 56
were reclassified as B. contaminans (Coutinho et al., 2015). The
epidemiological analysis carried out by our laboratory identified
B. cepacia and B. contaminans as emerging Bcc species associated
with CF infections (Cunha et al., 2003, 2007; Correia et al.,
2008; Coutinho et al., 2011b), since the overall prevalence
of these two species in CF patients is low (Moreira et al.,
2017).
In the present study, a set of epidemiologically related
B. cepacia and B. contaminans isolates, recovered from
contaminated saline solutions and from sputum samples of CF
patients, were used to examine the adaptation and survival
of these bacteria during long-term incubation, at 23◦C in
the dark, in artificially contaminated saline solutions deprived
of any nutrient source and supplemented with increasing
BZK concentrations. These conditions were used to mimic
the normal storage conditions of saline solutions for nasal
application from which the Bcc isolates were obtained.
A number of phenotypic characteristics were assessed in
regular intervals of time, up to 16 months, including cellular
viability, cell/colony diameter and morphology, as well as
pigmentation changes and the formation of cellular aggregates
and their characterization in terms of polysaccharide vs.
protein content.
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TABLE 1 | List of B. cepacia and B. contaminans clonal isolates used in this study, obtained from contaminated saline solutions or sputum samples from CF patients.
Species Isolate source Isolate ID Isolation date recA RFLP profile Ribopattern References
B. cepacia Saline solution IST612 November-December 2003 D 19 Cunha et al., 2007; Coutinho et al., 2015
IST701 March 2006 D 19
Patient AL IST4152 30/10/2003 D 19
IST4168 18/5/2004 D 19
IST4222 14/12/2005
B. contaminans Saline solution IST601 December 2003 E 17
Patient V IST4148 03/09/2003 E 17
IST4241 28/06/2004 E 17
IST4224 27/12/2005 E 17
MATERIALS AND METHODS
Bacterial Isolates and Culture Conditions
Five B. cepacia clonal isolates were analyzed in this study,
including two that were recovered from the contaminated
saline solutions detected by INFARMED and three collected
from a CF patient (patient AL) (Cunha et al., 2007). Of the
four B. contaminans clonal isolates analyzed, one was isolated
from contaminated saline solutions, in 2003, and three were
obtained from another CF patient (patient V) (Cunha et al.,
2007) (Table 1). Previous studies showed that the B. cepacia
and B. contaminans isolates recovered from saline solutions
were indistinguishable from those isolated from CF patients,
suggesting that they were epidemiologically related (Cunha
et al., 2007; Coutinho et al., 2015). These clinical isolates were
recovered, as part of the hospital routine, from the sputum of CF
patients under surveillance at Hospital de Santa Maria, Centro
Hospitalar Lisboa Norte (CHLN) EPE. Studies involving these
isolates were approved by the CHLN ethics committee and the
anonymity of the patients was preserved. Informed consent was
also obtained from all participants and/or their legal guardians.
All the methods were performed in accordance with the relevant
guidelines and regulations. Bacterial cultures were stored at
−80◦C in 1:1 (vol/vol) glycerol. When in use, bacteria were
cultivated in Pseudomonas isolation agar (PIA; Difco) plates. The
isolates used in the present study are listed in Table 1.
Long Term Adaptation Assays to
Benzalkonium-Supplemented Saline
Solutions
Liquid cultures of the Bcc isolates were grown in Luria-
Bertani (LB; NZYtech) medium (37◦C, 250 rpm) until mid-
exponential phase and centrifuged (10min, 7,000 rpm and
20◦C), washed twice with sterile NaCl 0.9%, and adjusted
to a standardized culture OD640nm of 0.2 in 150mL of
NaCl 0.9%. The resulting cellular suspension was used to
inoculate glass flasks containing (i) only NaCl 0.9%, (ii) NaCl
0.9% supplemented with 0.0053% (w/v) of BZK (SIGMA-
ALDRICH©) and (iii) NaCl 0.9% supplemented with 0.05%
(w/v) of BZK. The different BZK concentrations were chosen
on the basis of the expected effects each would have
in the bacterial populations. Since sub-minimum inhibitory
concentrations of BZK ranging from 10 to 50µg/mL have
been reported to affect bacterial survival without completely
killing the population (Kim et al., 2015), a concentration of
0.0053% (w/v) was used to guarantee a detectable effect in the
populations’ survival. A 10x higher BZK concentration (0.05%
(w/v)) was also tested to evaluate the effects of a presumably
lethal biocide concentration. Flasks were incubated at 23◦C,
in the dark, without agitation, during the entire course of
the experiment (16 months), to replicate the typical storage
conditions employed in the pharmaceutical industry for this type
of products.
Cell Viability Analysis
Bacterial samples were harvested from the glass flasks
representing each incubation condition, after gently
homogenizing the content, and, after serial dilution in NaCl
0.9%, with strong vortex agitation, they were plated onto Tryptic
Soy Agar medium (TSA; Difco). This solid growth medium
was used because it was found to be the most appropriate to
distinguish different colony morphologies. Plates were incubated
at 30◦C for 72 h in order to allow a clearer observation of the
size differences between normal and small colony variants
(SCVs) and other morphotypes. Samples collected from the
flasks containing BZK were filtered, after serial dilution, using
0.2µm pore size nitrocellulose membrane filters (Whatman) to
avoid cell growth inhibition by BZK. Cell viability assessment
was performed using conventional methods, based on colony
forming units (CFU), by estimating the number of viable bacteria
that can form colonies on an agar plate.
Colony Size and Morphology Assessment
Colony morphology analysis was performed using a
stereomicroscope and a Kl 2500 LCD cold light source
(Zeiss). The images were captured with an Axicam 503 color
camera (ZEISS) and colony diameters were determined using
the ZEN 2.3 software. At least 10 images were captured for each
sample. Approximately 100 colonies of each bacterial isolate
were randomly selected for diameter measurement.
Cell Size and Morphology Assessment
Cell size and morphological parameters, such as length and
width, were determined by fluorescence microscopy. Cells were
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harvested and stained with the LIVE/DEAD R© BacLightTM
Bacterial Viability Kit from Molecular Probes (Invitrogen Co.,
Spain). Briefly, 5mL of an overnight culture grown in liquid LB
at 37◦C, 250 rpm, were washed with NaCl 0.9% (centrifuged
twice for 10min at 7,000 rpm, 21◦C) and resuspended in 4mL
of NaCl 0.9%. From these cell suspensions, 30 µL were mixed
with 0.2 µL of each fluorophore (SYTO 9 and Propidium
iodide, each diluted 1:18 from the original stock) and left to
incubate at room temperature in the dark for 5min. Cells
were observed using a ZEISS Axioplan fluorescence microscope
with an HBO 50 burner and a HAL 100 halogen illuminator
and a filter with 450–490 nm excitation and 520 nm emission.
Images were captured with a microscope camera (ZEISS Axicam
503 color) using ZEN 2.3 (ZEISS) Imaging software. Image
analysis was carried out using ImageJ 1.52a. At least 6 images
were taken for each sample. Surface area was calculated as
4πr2 + 2πL and volume as 4/3 πr3 + πr2L, where r
represents radius or width/2, and L represents the length of
the cell.
Benzalkonium Susceptibility Assays (MIC
and MBC Determination)
To determine the susceptibilities to BZK (SIGMA-ALDRICH©)
displayed by the isolates under study, a modified broth minimum
inhibitory concentration (MIC) method was performed, using
96-well polystyrene microplates (Greiner Bio-One, Germany).
Cell cultures grown in liquid LB (37◦C, 250 rpm) until mid-
exponential phase were centrifuged (10min, 7,000 rpm, 20◦C),
resuspended in Mueller-Hinton (MH; Fluka Analytical) broth,
and adjusted to a standardized OD640 of 0.011. Of these cell
cultures, 190 µL were used to inoculate the wells of 96-well
microplates, together with 10 µL of BZK solutions at final
concentrations of 16, 32, 64, 128, 192, 256, 384, and 512µg/mL.
The 96-well microplates were incubated at 23◦C, in the dark, for
72 h. The lowest BZK concentration sufficient to inhibit bacterial
growth was defined as the MIC or susceptible concentration for
each Bcc isolate. These tests were performed in three biologically
independent experiments.
The minimum bactericidal concentration (MBC) was also
determined. After the above described 72 h incubation period, 4
µL of cell culture corresponding to each BZK concentration, were
removed from the 96-well microplates and spotted in TSA 1/10
solid medium, followed by incubation for 24 h at 37◦C. TheMBC
value was defined as the lowest BZK concentration for which
bacterial growth was no longer observed.
Composition of Cellular Aggregates
The polysaccharide (total sugars) content of the aggregate
structures formed during long-term incubation of B. cepacia and
B. contaminans isolates in the presence of BZK was assessed
using the phenol-sulfuric acid method (Dubois et al., 1956).
Bacterial samples were collected from each flask and centrifuged
for 5min at 10,000 rpm, 4◦C. The supernatant was discarded,
while the pellet was resuspended in 1mL of dH2O. The resulting
suspension was mixed with 1.5mL of phenol 0.05% (w/v) and
8mL of H2SO4 96%. After cooling, the OD490nm was measured.
The relative sugar content was determined using a standard
curve for the EPS (cepacian) produced by B. multivorans
(previously cepacia) IST408, as previously described (Coutinho
et al., 2011a). For protein quantification, the Biuret method
was applied (Herbert et al., 1971). Samples were collected from
the flasks and centrifuged for 10min at 4◦C, 15,000 rpm. The
supernatant was discarded, and the pellet resuspended in 1mL
of dH2O. The resultant cell suspension was mixed with 1mL of
dH2O and 1mL of NaOH (1mM), heated at 100
◦C for 5min
and let to cool at room temperature. Then, 1mL of 0.025%
CuSO4.5H2O (w/v) was added, followed by incubation at room
temperature for 5min. After centrifugation at 5,600 g, 20◦C,
for 5min, OD550nm was measured. To estimate the protein
content, a standard curve for bovine serum albumin (BSA)
was prepared.
Genome Analysis
De novo Genome Assembly
For genomic DNA extraction, bacterial cultures were prepared
by suspending isolated colonies from LB agar plates in
3mL LB broth, followed by overnight growth at 37◦C with
shaking at 250 rpm. Genomic DNA was extracted and
purified using a DNeasy Blood and Tissue kit (Qiagen,
Germany) according to the manufacturer’s instructions. DNA
concentration and purity were assessed using a Nanodrop ND-
1000 spectrophotometer. The draft genome sequences of the
B. cepacia isolates IST612 and IST701 were obtained using
Illumina sequencing technology. An initial quality control of
the genome sequences was performed with FastQC (Babraham
Bioinformatics). De novo assembly of genomes was performed
using SPAdes Genome Assembler v3.12.0 (Bankevich et al.,
2012). The contigs from the draft genomes were ordered
using the MAUVE software (Darling et al., 2004). Further
improvement of the assembly was achieved with Pilon (Walker
et al., 2014). After the assembly process, a scaffolding step was
applied using SSPACE (Boetzer et al., 2010), followed by its
improvement with Pilon. Quality control by QUAST (Gurevich
et al., 2013) was included after each assembly and scaffolding
improvement step.
Identification of Genes From the BZK Degradation
Pathway
Using NCBI nucleotide BLAST R©, the genome sequences of the
two B. cepacia isolates (IST612 and IST701) were searched for
the presence of the 15 genes encoding enzymes reported to be
involved in BZK degradation in B. cenocepacia AU1054 (Ahn
et al., 2016), which was used as a reference strain and its genome
retrieved from Burkholderia genome database (Winsor et al.,
2008). From this analysis, the DNA identity (%) and protein
identity and positives (%) of the BZK degradation pathway genes
between the reference genome and B. cepacia IST isolates was
obtained. Artemis Comparison Tool (ACT) (Carver et al., 2005)
was used to obtain information regarding putative gene location
(in bp), genome inversions and gene order. The BZK degradation
enzymes from AU1054 and the IST isolates were compared for
their theoretical features using ProtParam tool from ExPASy
(Gasteiger et al., 2005) and included as Supplementary Table S1.
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FIGURE 1 | Effect of long-term incubation in saline solutions (A1,A2) and saline solutions supplemented with 0.0053% (B1,B2) or 0.05% BZK (C1,C2) on the viability
of five B. cepacia isolates, obtained from contaminated batches of saline solutions (IST612 and IST701) and from the sputum of a CF patient (IST4152, IST4168, and
IST4222). Cellular viability was assessed as CFUs/mL, obtained through colony counts from three separate plates, corresponding to a range of three different serial
dilutions. The inserted panels show results from two independent incubation experiments for B. cepacia IST612, during the first month of incubation in each
experimental condition (a, b, c).
RESULTS
Long-Term Survival of B. Cepacia and
B. Contaminans Populations During
Extended Incubation in Saline Solution
Supplemented With BZK
To study the effects of prolonged exposure to stressful
environmental conditions, including nutrient starvation and the
presence of benzalkonium, mimicking those conditions used
during the storage of pharmaceuticals, the B. cepacia and B.
contaminans isolates described in Table 1 were inoculated into
glass flasks containing saline solution (NaCl 0.9%). These cell
suspensions were either unaltered or supplemented with two
levels of BZK [0.0053% (w/v) or 0.05% (w/v)] and kept at 23◦C
in the dark.
Cell viability (as colony forming units, CFU/mL) obtained
for the 5 clonal variants of B. cepacia (Figure 1) and the 4
clonal variants of B. contaminans (Figure 2) tested decreased
throughout the incubation period (16 months) in a BZK
dose-dependent manner. The highest and faster decrease in
the viable original population was verified in the presence
of BZK (∼99.9% for both of the concentrations tested). For
0.05% BZK, this decrease occurred within the first month of
incubation, after which the percentage of viable population
remained broadly unchanged, corresponding to approximately
0.1% of the initial population. Contrastingly, the viability loss
verified for the bacterial populations incubated with 0.0053%
BZKwas continuous throughout the incubation period and, even
after 16 months, the viability of the cellular populations had not
yet stabilized.
Bacterial populations incubated in saline solutions (NaCl
0.9%) without BZK had a negligible specific death rates for
approximately 10 months, after which a clear and fast decline
of the viable bacterial population (in the range of 91–99%)
occurred (Figures 1A1,A2, 2A1,A2). The addition of 0.0053%
BZK caused a continuous decline of viability during incubation
(Figures 1B1,B2, 2B1,B2), and the specific death rate increased
at the higher BZK concentration tested. The significant loss of
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FIGURE 2 | Effect of long-term incubation in saline solutions (A1,A2) and saline solutions supplemented with 0.0053% (B1,B2) or 0.05% BZK (C1,C2) on the viability
of four B. contaminans isolates, obtained from contaminated batches of saline solutions (IST601) and from the sputum of a CF patient (IST4148, IST4241, and
IST4224). Cellular viability was determined as CFUs/mL, obtained through colony counts from three separate plates, corresponding to a range of three different serial
dilutions. The inserted panels show results from two independent incubation experiments for B. contaminans IST601, during the first month of incubation in each
experimental condition (a,b,c).
viability was followed by a period of negligible death rate on the
addition of 0.05% BZK (Figures 1C1,C2, 2C1,C2) suggesting the
development of a persister population.
Differences in the viability decrease profiles obtained for
the different clonal isolates (5+4) corresponding to each
experimental setting are not considered significant. Although
they were single long-term experiments performed at 23◦C
for more than 1 year, altogether, the results obtained under
the different conditions tested validate the average viability
profiles (Figure 1C1). Nevertheless, the saline isolates B. cepacia
IST701 and IST612 exhibited the least similar viability profiles
in terms of CFU counts, differing by approximately one order
of magnitude for the majority of the timepoints analyzed.
Although it is not possible to be conclusive, since we are
comparing single experiments, it is interesting to note that
the isolate that appears to be more BZK tolerant, IST701, was
isolated from a saline solution for nasal application 3 years
later than IST612, when the biocide concentration added to the
pharmaceutical product was higher. Although other differences
could be identified between the two groups of clonal Bcc
isolates examined, namely the level of tolerance to the lack
of nutrients and presence of different BZK concentrations, the
limitations associated with the counting of CFUs/mL draws
robust conclusions. In fact, the formation of macroscopically
visible cellular aggregates in the presence of BZK (as described
below) might lead to an underestimation of cellular viability,
and the type of aggregates was found to be species isolate-
dependent. Despite thorough homogenization by vortexing
the diluted samples prior to plating, in order to disrupt the
aggregate structures, heterogeneity concerning the number/size
of the aggregates in each sample is anticipated. This limitation
contributes to the variation among experimental CFU values,
especially registered for samples obtained from saline solutions
supplemented with higher BZK concentrations after extended
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TABLE 2 | MIC and MBC values toward BZK obtained for B. cepacia and
B. contaminans isolates examined in this study.
Strain Original isolate MIC (µg/mL) MBC (µg/mL)
B. cepacia IST612 192 192
IST4152 192 192
IST4168 192 192
B. contaminans IST601 128 128
IST4241 128 128
IST4224 128 128
Values are means of at least two replicates and three biologically
independent experiments.
incubation periods, where the number and size of the cell
flocks increase.
The minimum inhibitory concentrations (MIC) and
minimum bactericidal concentrations (MBC) were determined
for several isolates, also mimicking the storage conditions for
saline solutions (23◦C) (Table 2). However, these values were
obtained in growth medium, while the long-term viability
experiments were performed under nutrient limitation in a
saline solution. The MIC values obtained are situated within the
upper range of values previously reported in the literature for
B. cepacia (50–200µg/mL) (Rose et al., 2009; Kim et al., 2015).
Differences between the clonal isolates of the two Bcc species
tested were also detected, with the B. cepacia isolates displaying
higher resistance to BZK in comparison with the B. contaminans
isolates tested.
The MBC and MIC values were the same for all the isolates
analyzed, consistent with what has been reported for other
relevant Gram-negative microbial pathogens when exposed to
BZK (Morrissey et al., 2014), since for bactericidal drugs like
BZK, the MBC values are usually the same as the MIC values,
differing by no more than four times the MIC.
Colony Size Reduction and Other
Morphology Alterations Observed During
Extended Incubation in Saline Solutions
Supplemented With BZK
Different incubation conditions resulted in the development
of heterogeneous bacterial populations, characterized by major
phenotypic differences, including a diversification of colony
morphotypes and a clear decrease in colony diameter. At
initial inoculation (“Day-zero”), all of the colonies exhibited
a similar rough morphology and size (Figure 3). After 16
months of incubation in saline solutions without BZK, most
colonies remained rough (∼95.5%), but some smooth colonies
were observed (∼4.5%). More smooth colonies evolved in
0.0053% BZK (∼68.7%), while the higher concentration of BZK
(0.05%) led to complete replacement of the rough morphology
with smooth colonies (Figure 3). Evolved colonies also lost
pigmentation and, in the case of B. contaminans isolates, became
more mucoid than B. cepacia isolates (Figure 3).
Long-term incubation in the aforementioned conditions also
led to colony size variation, as evidenced by the emergence
of smaller-sized colonies within the first 30 days of the
experiment. However, after the 82nd day of incubation, their
percentage increased significantly and was quantified (Figures 4,
5). Although small colonies (≤ 0.5mm in diameter) were also
observed in the absence of BZK, they were much more common
in the presence of the preservative, representing between 5
and 100% of the total number of colonies, depending on
the Bcc isolate tested (Figures 4, 5). After 48 h of incubation,
colonies obtained from saline solutions exhibited an average
diameter of 1.6mm (±0.03), while colonies isolated from
solutions containing 0.0053 and 0.05% BZK displayed mean
diameters of 1.5mm (±0.02) and 1.1mm (±0.06), respectively.
The development of smaller-sized colonies, as a result of the
extended incubation period, translated into a decrease of colony
size of approximately 26%, in the case of bacterial populations
incubated in saline solutions without BZK. This decrease was
more significant for cellular populations incubated with 0.0053
and 0.05% BZK, corresponding to ∼45 and ∼52%, respectively.
The overall decrease in colony size was a dose-dependent
response to higher BZK concentrations for both B. cepacia and
B. contaminans isolates (Figure 6). However, cell populations
of B. contaminans incubated in the presence of the same BZK
concentration were generally composed by bigger colonies, when
compared to the B. cepacia populations (Figure 6). A correlation
between the frequency of appearance of small-sized colonies
and the percentage of the persistent population could not
be established.
Smaller-sized colonies isolated from saline solutions without
BZK were found to revert to the original phenotype after the
2nd passage in a stress-free environment (TSA plates). The same
was generally observed for smaller colonies isolated from saline
solution containing 0.0053% BZK. However, colonies obtained
from saline solutions supplemented with the highest biocide
concentration (0.05%) maintained the smaller phenotype, which
indicates that, in this particular condition, the smaller colony size
might become an inheritable trait. The results indicate that the
stability of the smaller colony size phenotype is influenced by
the intensity of the stress condition to which cells are exposed. It
should also be noted that colonies exhibiting diameters≤0.5mm
were considered as smaller-sized colonies, while only those
presenting one-tenth the size of the original colonies were termed
small colony variants (SCVs), by definition (Proctor et al., 2006).
Reduction of Cell Size During Extended
Incubation in Saline Solution
Supplemented With BZK
Besides the observed effects exerted by extended incubation
in saline solutions supplemented with 0.05% BZK on the
reduction of colony size, the presence of BZK also induced a
decrease of cell size, as observed using fluorescence microscopy.
Cell length and width measurements indicated that unlike
normal-sized colonies, smaller-sized colonies of both B. cepacia
and B. contaminans were composed of smaller cells with
an atypical shape, closer to coccus/coccobacilli (Figure 7).
After 3 months of incubation, the average surface area
and volume of normal cells were 546.1 (±51.2) µm2 and
2945.6 (± 412.1) µm3, respectively, while the average surface
area of smaller cells was 348.8 (± 55.0) µm2 and the
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FIGURE 3 | Different colony morphotypes exhibited by B. cepacia IST612 and B. contaminans IST601 cellular populations incubated in saline solutions without BZK,
and in saline solutions supplemented with 0.0053% or 0.05% BZK, after 16 months of incubation. Colony morphologies were compared with those obtained for the
same bacterial isolates at initial inoculation (“day-zero”) in the same conditions. It is possible to observe differences in the colony size, morphology, and pigmentation.
average volume was 1360.3 (± 348.7) µm3 (Figure 7). Thus,
surface area is reduced, on average, by ∼35% and volume
by∼55%.
BZK as an Inducer of the Formation of
B. cepacia and B. contaminans Aggregates
and Their Characterization
Throughout the course of the incubation experiments, it was
possible to observe, with the naked eye, the formation of a white
material that deposited on the bottom of the flasks containing
0.05% BZK, after the 30th day of incubation.
Microscopic observation of samples from cell suspensions
belonging to IST612 (B. cepacia) and IST601 (B. contaminans)
was performed using fluorescence microscopy, after 16 months
of incubation in the three stress conditions described, where
live cells were stained with SYTO 9 (green) and dead
cells were stained with propidium iodide (red) (Figure 8).
Isolates incubated in saline solutions without BZK exhibit a
dispersed cellular population, essentially composed of single cells
(Figures 8A1,B1). B. cepacia bacterial populations, incubated
in the presence of 0.0053% BZK, were generally composed
by cellular aggregates of intermediate size, with mostly dead
or membrane compromised cells. Nevertheless, some live cells
were spotted, residing within those aggregates (Figure 8B2).
The B. contaminans population that was incubated in the same
conditions did not display any aggregates of considerable size and
were composed of small groups of 2–5 cells (Figure 8A2). Most
cells were also dead/membrane compromised. For the highest
BZK concentration (0.05%), the bacterial populations showed a
clear tendency to form denser and bigger aggregate structures
(Figures 8A3,B3). In general, the B. cepacia isolates incubated in
0.05% BZK exhibited a homogeneously turbid appearance, while
the B. contaminans isolates formed visible floccular structures.
To assess the composition of the aggregate-like structures
produced by the Bcc isolates under study, triggered by BZK,
the ratio between polysaccharide and protein concentration
was determined (Figure 9). After 18 months of incubation in
saline solutions or saline solutions containing two different
BZK concentrations, the polysaccharide content of the cellular
aggregates was higher, in comparison with the values obtained
after one month, for both B. cepacia and B. contaminans
populations (Figure 9A). At initial inoculation (“time zero”),
polysaccharide was not detected within the bacterial samples
analyzed (Figure 9A). The results indicate that the composition
of the cellular aggregate’s matrix changed over time, becoming
richer in (poly)saccharide during long-term incubation, as
indicated by the polysaccharide vs. protein plot (Figure 9C).
This increase was particularly notorious for the highest 0.05%
BZK, for which the polysaccharide content increased the
most between the three time-points analyzed (Figure 9A).
These observations suggest that cellular populations adapt
to the presence of higher BZK concentrations by producing
aggregates rich in polysaccharide, which is also corroborated by
the macroscopic observation of these structures. The cellular
protein concentration remained relatively constant throughout
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FIGURE 4 | Evolution of cell viability ( 0.05% BZK) and percentage of smaller-sized colonies ( % Smaller-sized colonies 0.05% BZK) obtained for the B. cepacia
bacterial populations during 16 months of incubation in saline solutions containing 0.05% BZK. The percentage of smaller-sized colonies only started to be registered
at the 82nd day. Cell viability values hereby plotted correspond to those represented in Figure 1.
the incubation time, for both cellular populations incubated
either without BZK or with the lower concentration (0.0053%
w/v) of the biocide (Figure 9B). The increase in the protein
concentration registered after 1 month of incubation with 0.05%
BZK suggest that BZK may be used as carbon and energy source
by Bcc bacteria as reported before (Geftic et al., 1979). The
decrease of protein concentration registered at the 18th month of
incubation with 0.05% BZK could be due to protein degradation
(Figure 9B).
Identification of a Putative BZK
Degradation Pathway in B. cepacia Isolates
To confirm the existence of a metabolic pathway responsible for
BZK degradation, two B. cepacia isolates, IST612 and IST701,
recovered from intrinsically contaminated saline solutions in
2003 and 2006, respectively, were selected for genomic analysis.
The genome sequences of those isolates were compared against
the nucleotide sequences of 15 genes described to be involved in
BZK degradation in B. cenocepacia AU1054 (Ahn et al., 2016),
using the NCBI nucleotide BLAST tool. All the 15 genes encoding
BZK degradative enzymes have corresponding homologs in the
B. cepacia IST612 and IST701 genomes (Figure 10), confirming
the existence of a degradation pathway for BZK.
Further characterization of the BZK degradation pathway
genes aimed at inferring gene organization and synteny, and
to assess the occurrence of genomic rearrangements. The BZK
degradation pathway genes were found to be distributed across
the three chromosomes of B. cenocepacia AU1054, with a given
transcriptional orientation (Figure 10A). In the draft genome
sequence of B. cepacia IST612, we were able to find the homolog
Frontiers in Bioengineering and Biotechnology | www.frontiersin.org 9 June 2020 | Volume 8 | Article 630
Tavares et al. B. cepacia and B. contaminans Adaptation to Benzalkonium
FIGURE 5 | Evolution of cell viability ( 0.05% BZK) and percentage of smaller-sized colonies ( % Smaller-sized colonies 0.05% BZK) obtained for the B.
contaminans bacterial populations during 16 months of incubation in saline solutions containing 0.05% BZK. The percentage of smaller-sized colonies only started to
be registered at the 82nd day. Cell viability values hereby plotted correspond to those represented in Figure 2.
genes for the BZK degradation pathways distributed across
scaffolds 1, 3, and 4, with 14 of the genes showing the same
transcriptional orientation as in the AU1054 genome sequence.
The homolog gene to Bcen_5677 (identified in the scheme as
15), encoding an aldehyde dehydrogenase, was found in the
same scaffold as the genes of chromosome I of AU1054, with a
reversed transcriptional orientation when comparing to AU1054.
Considering that in the genome of AU1054, Bcen_5677 is found
in chromosome III, and that IST612 sequence is an Illumina
draft genome, this reversed transcriptional orientation may be
an artifact from the scaffold definition process. In the draft
genome sequence of B. cepacia IST701, the BZK degradation
genes are distributed across 8 scaffolds, with two of the genes
divided in two scaffolds. Comparing with the transcriptional
orientation of the genes in the IST612 genome, there are 9 genes
with reversed transcriptional orientation in the IST701 genome,
strongly indicating several genome rearrangements of large
genome sequences (Figure 10A). Although no SNPs were found
among the two IST isolates for the BZK degradation pathway
genes, these isolates’ genes share DNA percentage identities
varying between 89 and 96 and protein percentage identity
varying between 90 and 100% identity with B. cenocepacia
AU1054 gene sequences (Figure 10B). The positive percentage
provided by NCBI BLASTp R© tool, that accounts for the type
of amino acid substitution, indicate protein similarities equal
or higher than 94%, emphasizing the high conservation of the
protein sequences, as also documented by the protein theoretical
features (Supplementary Table S1).
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FIGURE 6 | Colony diameter distribution of the cell populations corresponding to B. cepacia IST612 (A) and B. contaminans IST601 (B) incubated for 16 months
under three different stress conditions. The colony diameters of the original isolates, grown on LB medium, were also assessed and used as a control. From 30 to 260
individual colonies were selected for measurement. Mean colony diameters ± SD are also plotted. The results of the Mann–Whitney U-test (****P < 0.0001, n.s. not
significant) are indicated.
FIGURE 7 | Scatter plot of cell length and width of B. cepacia (IST612, IST4152, and IST4168) and B. contaminans (IST601, IST4241, and IST4224) populations
recovered from saline solutions containing 0.05% BZK after 3 months of incubation, corresponding to the normal sized clonal variant (dark gray) and to the small
clonal variant (light gray). The results of the Mann-Whitney u-test (***P ≤ 0.001, n.s. not significant) are indicated.
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FIGURE 8 | Microscopic observation of the structures formed by B. cepacia IST612 and B. contaminans IST601, after 16 months of incubation in saline solutions
supplemented with increasing concentrations of BZK. (A1,B1) Control cells, incubated in saline solution (NaCl 0.9% (w/v)); (A2,B2) Cells incubated in saline solution
supplemented with 0.0053% (w/v) of BZK; (A3,B3) Cells incubated in saline solution supplemented with 0.05% (w/v) of BZK. Cellular viability was assessed through
co-staining of cells with SYTO 9 (green) and propidium iodide (red). Images were acquired using a fluorescence microscope (the same settings were applied for each
image) and are equally scaled to allow direct comparison.
DISCUSSION
Bacteria of the Burkholderia cepacia complex (Bcc) are
characterized by a remarkablemetabolic diversity and persistence
and survival in nutrient-limited aqueous environments. For
that reason, water raises a particular concern in industrial
pharmaceutical settings, where it is used as a raw material
(Torbeck et al., 2011; Cundell, 2019; Tavares et al., 2020).
In fact, pharmaceutical-grade water has been identified as the
underlying cause behind several Bcc outbreaks related to the
use of contaminated products (Torbeck et al., 2011; Cundell,
2019). Moreover, the lack of good manufacturing practices in
industrial settings, including deficient quality control and poorly
designed water systems, are also among the reasons behind the
presence of Bcc in pharmaceutical products (Ali, 2016). The
present work provides insights into the phenotypic changes that
occurred during the adaptation of different clonal isolates of B.
cepacia and B. contaminans to long-term incubation in saline
solutions and in saline solutions supplemented with different
concentrations of benzalkonium chloride (BZK), mimicking the
effects of nutrient starvation and the presence of this biocide in
pharmaceutical product formulations.
The isolates examined in this work are epidemiologically
related and were obtained from batches of contaminated saline
solutions for nasal application or from the sputa of two CF
patients (Cunha et al., 2003, 2007; Coutinho et al., 2015).
Despite the 16 months of incubation in saline solution without
any source of carbon or energy, under the test conditions,
we found that viable cells of B. cepacia and B. contaminans
could still persist and be recovered using a culture-based
method. The same was observed for isolates maintained in
saline solutions containing 0.0053% or 0.05% BZK. For the
higher BZK concentration, a period of rapid exponential death
with a duration of approximately 1 month was followed by a
stabilization of the CFU counts. This biphasic killing curve is
characteristic of the enrichment of the original population with
persister cells (Fauvart et al., 2011; Maisonneuve and Gerdes,
2014; van den Bergh et al., 2017) and was accompanied by
marked phenotypic alterations of colony and cell morphology
and aggregation, as discussed later. Previous reports have also
shown that Bcc species can survive and remain viable for
prolonged periods of time in water without any source of
nutrients (Carson et al., 1973; Zanetti et al., 2000; Vermis
et al., 2003; Moore et al., 2008; Pumpuang et al., 2011; Torbeck
et al., 2011; Gilbert and Rose, 2012; Ahn et al., 2014) and
a “Pseudomonas cepacia” strain survived during 14 years of
incubation in an ammonium acetate solution supplemented with
0.05% BZK (Geftic et al., 1979). Since BZK is used in a variety of
commercial products in concentrations ranging from 0.02 to 5%
(200–50,000µg/mL) (Kim et al., 2015) and as a preservative in
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FIGURE 9 | Levels of polysaccharide (A), protein (B) and the ratio of polysaccharide vs. protein (C) produced by B. cepacia IST612 and the B. contaminans IST601,
assessed by the phenol-sulphuric and biuret methods, respectively, and expressed in mg per mL of bacterial sample, at initial incubation (“Time = 0”) and after, 1 and
18 months of incubation in saline solutions and saline solutions supplemented with 0.0053% (w/v) or 0.05% (w/v) BZK. The results are means of two independent
experiments with three replicates each. At initial inoculation (“Time = 0”) no polysaccharide content was detected. The results of the 2-way ANOVA test (*P < 0.05,
**P ≤ 0.01, ***P ≤ 0.001, ****P < 0.0001, ns not significant) are indicated.
concentrations between 0.004 and 0.02% (40–200µg/mL) (Kaur
et al., 2009), the isolates studied in this work would have not been
killed at the lowest commercially used concentrations or at any
preservative concentrations.
Long-term incubation in the different stress conditions
examined in this study resulted in the appearance of distinct
colony morphotypes. Colonies isolated from saline solutions
under nutrient starvation produced a rough and nonmucoid
morphology throughout the experiment. However, incubation
in the presence of BZK was associated with a dose-dependent
smoother and mucoid phenotypes. In Bcc bacteria, the transition
from a mucoid to a nonmucoid phenotype is more common in
the context of CF infections, where the nonmucoid phenotype
is associated with increased virulence, leading to a faster lung
function decline (Zlosnik et al., 2008, 2011). In contrast, the
mucoid phenotype is associated with persistence and decreased
virulence, which might be more favorable in the presence of
BZK, that can be used as source of carbon and energy for
exopolysaccharide biosynthesis, as our results suggest.
A clear tendency for a gradual and consistent decrease in
colony size during long-term incubation in saline solutions was
also observed. This alteration pattern was further enhanced in
the presence of BZK in a dose-dependent manner. However, the
development of colony variants that can really be considered
as small colony variants (SCVs), consisting of slow-growing
bacterial subpopulations characterized by being one-tenth the
size of the original-type bacteria (Proctor et al., 2006; Johns
et al., 2015), was only observed to arise for the higher
BZK concentrations (0.05%), constituting 100% of B. cepacia
isolates IST612, IST701 and B. contaminans isolate IST4241
populations, after 16 months of incubation. Remarkably, the
smaller-sized variants isolated from saline solutions without
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FIGURE 10 | Genomic organization and transcriptional orientation of the 15 homologs of the B. cenocepacia AU1054 BZK catabolism genes, identified within the
genomes of B. cepacia IST612 and IST701. Genes are represented by labeled arrows (A) and their respective locus-tag, products, percentage DNA identity, and
percentage protein identity and positives (from BLASTp tool) between reference and IST isolates are listed below (B). The IST701 BZK catabolism genes are colored in
green and red, depending on whether the genes are encoded in the same or reversed transcriptional orientation of that of IST612, respectively. Gene size, distance
and positioning in the chromosomes and scaffolds are not to scale.
BZK or containing 0.0053% BZK (26–45% size reduction in
comparison to the original colonies), reverted to the original
morphology immediately after the second passage in optimal
growth conditions. It is likely that the SCVs that emerged upon
adaptation to higher BZK concentrations have undergone more
permanent genetic changes, maintaining the SCV phenotype.
SCVs usually have deficiencies in the electron transport chain,
which translate into lower ATP production and reduced
metabolism (Proctor et al., 2006; Johns et al., 2015). Since ATP
production is essential for cell wall and membrane biosynthesis,
as well as for pigment production, the “dormancy” state that
characterizes SCVs might explain the reduced size of the colonies
formed and specific growth rate, and the lack of pigmentation
(Proctor et al., 2006; Johns et al., 2015). Conversion into a state
of low metabolic activity (dormancy) contributes to bacterial
persistence and tolerance to antimicrobial agents (Maisonneuve
and Gerdes, 2014; Fisher et al., 2017), leading to recurrent and
often fatal infections (Häussler et al., 2003; Malone, 2015).
In terms of length and width, cells also became more
rounded/coccoid in response to BZK. Many Gram-negative
pathogens develop smaller coccoid forms in response to stress,
such as long-term incubation in fresh or salt water (Yang
et al., 2016). Since nutrient acquisition relies on diffusion and
capture of molecules at the cell surface, smaller cells can capture
molecules present in very low concentrations to support their
metabolic requirements (Bergkessel et al., 2016). The relationship
between cell size and nutrient availability may be related with
fatty acid biosynthesis. A model proposed for Escherichia coli
suggests that the flux of nutrients into the cell controls the
synthesis of fatty acids which, in turn, controls cell size through
modeling of the cell membrane surface area and cytoplasmic
volume (Yao et al., 2012). A recent study performed in our
lab also demonstrated a clear length and height decrease of B.
cenocepacia cells during more than 3 years of chronic infection,
suggesting that the population converged evolutionarily toward
the minimization of bacterial size (Hassan et al., 2019). Small
microbial cell size might allow evasion from important host
defenses and cell shape itself has been suggested as a virulence
trait (Vadia et al., 2017). Therefore, the progressive decrease
of cell size induced by BZK might favor persistent infection
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and more efficient nutrient acquisition, suggesting an additional
danger if contaminated saline solutions are used by CF patients.
One of the most striking observations from this work was
the formation of macroscopically visible cellular aggregate-like
structures, in the presence of the higher biocide concentration
tested (0.05% w/v), especially for the B. contaminans isolates’
populations. The characterization of the aggregates’ matrix
revealed that these structures were rich in (poly)saccharide.
Moreover, the polysaccharide content significantly increased
during long-term incubation, a tendency that was accompanied
by the development of visually denser cellular aggregates. This
biomass increase suggests that BZK might be catabolized and
used as carbon and energy source. Since polysaccharide and cell
aggregates’ production implies a significant carbon and energy
expense, the low polysaccharide levels displayed by the bacterial
populations incubated in the absence of BZK or with the
lower BZK concentration is consistent with the carbon and
energy starvation/limitation expected in these environments.
Overall, in the presence of BZK, polysaccharide production
might constitute a long-term adaptation mechanism, allowing
the maturation of the aggregates’ structure and increasing the
chances of bacterial survival. Although long-term exposure to
BZK chloride was previously associated with an evolutionary
response of a microbial community toward multidrug resistance
(Tandukar et al., 2013), in the present study it is for the
first time described the impact that the presence of BKZ
has in Bcc aggregate formation. In saline incubation media
with no source of carbon and energy, B. cepacia and B.
contaminans bacterial populations were also able to survive,
implying a “sacrifice-for-survival” mechanism (Snoussi et al.,
2018), in which the intracellular components released by dead
cells might be used to maintain a smaller viable population.
Additionally, and despite the dose-dependent BZK’s deleterious
effects that stimulate an initial viability loss, after adaptation to
the biocide, especially at the maximum concentration, it was
likely used as carbon and energy source to maintain cellular
viability and support polysaccharide-rich cellular aggregates’
formation during extended incubation. These results strongly
suggest that BZK can be catabolized by B. cepacia and B.
contaminans, even when present as the sole carbon and energy
source. Biodegradation of Benzalkonium chlorides has also been
reported to occur within microbial communities containing
members of the Burkholderia genus (Oh et al., 2014). Those
microbial communities were able to metabolize Benzalkonium
chlorides as a sole carbon and energy source through dealkylation
reactions, within 12 h (Oh et al., 2014). Metatranscriptomic
studies revealed that the dealkylation process was mediated
by an amine oxidase, while several other enzymes involved in
energy generation processes (such as the TCA cycle) and fatty
acid metabolism, as well as monooxygenases, dioxygenases, and
dehydrogenases were also upregulated upon BAC exposure (Oh
et al., 2014). When in microbial communities or as isolated
cells, Bcc strains were found to possess high inherent tolerance
to BZK, a feature attributed to the activity of efflux pumps
and their capacity to catabolize BZK (Ahn et al., 2016). In
fact, the N dealkylation-dependent degradation of BZK by B.
cenocepacia was identified as an effective detoxification process
and metabolic benefit for the use of an alternative energy and
carbon source, and the 15 genes involved in the degradation
pathways were identified in strain AU1054 genome (Ahn et al.,
2016). In the present study, these 15 genes were found to be
present in the genomes of the B. cepacia IST isolates tested,
as suggested by the high percentage of DNA and protein
identity with AU1054 catabolic genes/proteins. In summary, the
BZK-dose dependent increase of biomass and polysaccharide-
rich aggregates after extended incubation in saline solution
with this biocide together with the presence in the genome
of the B cepacia IST isolates of genes/proteins with a very
high DNA/protein sequence identity to those of the BZK
degradation pathway previously identified in B. cenocepacia AU
1054, strongly support our hypothesis that BZK is used as
carbon- and energy- source producing those polysaccharide-
rich-cell aggregates.
This study highlights the metabolic capacity of Bcc bacteria,
the potential hazards posed by the presence of these opportunistic
pathogens in pharmaceutical products, and the inefficacy of using
sub-critical concentrations of specific biocides as a preventive
measure to avoid Bcc-related contaminations. Results reinforce
the urgent need to re-evaluate the application of biocides
in non-sterile pharmaceutical products’ formulations and the
concentrations used, in order to prevent contamination and
subsequent infection outbreaks. Formation of SCVs raises
a serious problem for clinical microbiologists, since their
reduced size and growth rate hamper detection by conventional
diagnostic tests, more than often leading to false-negative
results (Torbeck et al., 2011), especially when standardized
incubation periods are used, which are not sufficient to
allow SCV detection with the naked eye (Jimenez et al.,
2015). The alterations in cellular shape that occur in response
to long-term incubation under nutrient starvation may also
hinder Bcc eradication from pharmaceutical products, since
these particular bacterial cells might be able to pass through
the membranes used during filtration processes and induce
contamination (Jimenez, 2004). Bcc bacteria have a slower
growth rate in comparison with other microorganisms, therefore
in samples containing mixed bacterial populations, their
presence might be masked by other fast-growing bacteria
(Henry et al., 1999). If these bacteria are not detected during
quality control, contaminated products wrongly considered
as safe might reach the market and be used by patients
at risk, which negatively affects their treatment options
and prognosis. Bcc tolerance to BZK appears to be a
multifactorial phenomenon, involving not only the induction
of the genetic machinery required for the use of the biocide
as a carbon and energy source, but also the emergence of
different phenotypes and formation of cell aggregates rich in
polysaccharide. The comparative genomic, transcriptomic and
quantitative proteomic analyses of the several representative
clonal morphotypes (SCVs vs. normal sized colonies and rough
vs. smooth colonies) of each original bacterial population
obtained during long-term incubation under nutrient starvation
in saline solutions and in the presence of increasing BZK
concentrations would be of utmost interest to understand the
underlying mechanisms.
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